In the realm of pharmaceutical development, specific chemical intermediates serve as the foundational building blocks for life-saving medications. Olaparib (CAS 763113-22-0) is one such critical intermediate, widely recognized for its role as a potent PARP inhibitor used in targeted cancer therapies.

Olaparib's significance lies in its mechanism of action: it selectively inhibits Poly(ADP-ribose) polymerase (PARP) enzymes, which are essential for repairing single-strand DNA breaks. In cancer cells with defects in other DNA repair pathways, such as those with BRCA mutations, inhibiting PARP leads to the accumulation of DNA damage and ultimately cell death. This targeted approach has revolutionized the treatment of certain cancers, including specific types of ovarian, breast, pancreatic, and prostate cancers.

As a dedicated manufacturer and supplier of Olaparib, our focus is on delivering a product of exceptional quality and purity, consistently exceeding 99%. This high standard is crucial for researchers and pharmaceutical formulators who rely on precise chemical compositions for their drug development pipelines. Whether you are a scientist investigating new therapeutic applications or a procurement manager securing raw materials, our commitment is to provide a reliable supply chain.

Sourcing Olaparib from a reputable manufacturer in China ensures access to competitive pricing and consistent product availability, whether for laboratory research or larger-scale manufacturing. We understand the rigorous demands of the pharmaceutical industry and are equipped to meet them with a product that adheres to strict quality control measures. Our chemical properties, including molecular formula (C24H23FN4O3) and molecular weight (434.47 g/mol), are thoroughly documented to support your development processes.

The therapeutic applications of Olaparib are extensive, making it a highly sought-after pharmaceutical intermediate. By choosing us as your Olaparib supplier, you gain a partner dedicated to supporting your efforts in developing innovative cancer treatments. We encourage researchers and companies to buy Olaparib from us, confident in our ability to deliver quality and reliability.